SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports

An investigation on the association between sodium glucose co‐transporter 2 inhibitors use and acute pancreatitis: A VigiBase study

(2021) Ioana Frent et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Pancreatic safety of sodium‐glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis

(2020) Huilin Tang et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

An update on the safety of SGLT2 inhibitors

(2019) André J Scheen   Expert Opinion On Drug Safety

WITHDRAWN: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition

(2019) Pouya Saeedi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Empagliflozin-Induced Pancreatitis

(2018)   ANNALS OF PHARMACOTHERAPY

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels

(2018) Takayoshi Suga et al.   Molecular Metabolism

SGLT2 Inhibitors Through the Windows of EMPA-REG and CANVAS Trials: A Review

(2017) Ashu Rastogi et al.   Diabetes Therapy

SGLT2 Inhibitors Through the Windows of EMPA-REG and CANVAS Trials: A Review

(2017) Ashu Rastogi et al.   Diabetes Therapy

Canagliflozin-Associated Acute Pancreatitis

(2016) Rajanshu Verma   AMERICAN JOURNAL OF THERAPEUTICS

OpenVigil FDA – Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications

(2016) Ruwen Böhm et al.   PLoS One

Canagliflozin-induced pancreatitis: a rare side effect of a new drug

(2015) Mudit Chowdhary et al.   Therapeutics and Clinical Risk Management

Global estimates of diabetes prevalence for 2013 and projections for 2035

(2013) L. Guariguata et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Data Mining of the Public Version of the FDA Adverse Event Reporting System

(2013) Toshiyuki Sakaeda et al.   International Journal of Medical Sciences

SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects

(2012) Ele Ferrannini et al.   Nature Reviews Endocrinology